Week 96 efficacy and safety of cabotegravir plus rilpivirine every 2 months in ATLAS-2M Phase IIIb study
Hans Jaeger,Edgar Overton,Gary Richmond,Giuliano Rizzardini,Jaime-Federico Andrade-Villanueva,Rosie Mngqibisa,Antonio Ocampo Hermida,Anders Thalme,Paul Benn, Yuanyuan Wang,Krischan Hudson,David Margolis,Christine Talarico,Kati Vandermeulen,William Spreen HIV MEDICINE（2021）
AI 理解论文
溯源树
样例
